Heidelberg Pharma AG
XETRA:HPHA
Heidelberg Pharma AG
XETRA:HPHA
Price:
3.05
EUR
Market Closed
Market Cap:
€142.7m
Balance Sheet
Balance Sheet Decomposition
Heidelberg Pharma AG
Heidelberg Pharma AG
Balance Sheet Decomposition is not available for
Heidelberg Pharma AG
Heidelberg Pharma AG
Balance Sheet
Heidelberg Pharma AG
Heidelberg Pharma AG
Currency: EUR
| Nov-2015 | Nov-2016 | Nov-2017 | Nov-2018 | Nov-2019 | Nov-2020 | Nov-2021 | Nov-2022 | Nov-2023 | Nov-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
5
|
30
|
19
|
10
|
5
|
6
|
81
|
43
|
29
|
|
| Cash Equivalents |
1
|
5
|
30
|
19
|
10
|
5
|
6
|
81
|
43
|
29
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
2
|
6
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
5
|
10
|
12
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Total Current Assets |
2
|
5
|
31
|
20
|
12
|
8
|
9
|
88
|
57
|
48
|
|
| PP&E Net |
1
|
1
|
1
|
2
|
2
|
3
|
4
|
4
|
4
|
3
|
|
| PP&E Gross |
1
|
1
|
1
|
2
|
2
|
3
|
4
|
4
|
4
|
3
|
|
| Accumulated Depreciation |
3
|
3
|
3
|
4
|
4
|
5
|
6
|
6
|
7
|
8
|
|
| Intangible Assets |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Goodwill |
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Assets |
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
|
| Total Assets |
12
N/A
|
15
+26%
|
41
+172%
|
31
-25%
|
23
-26%
|
20
-15%
|
22
+11%
|
101
+363%
|
70
-30%
|
61
-14%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
2
|
0
|
1
|
3
|
1
|
3
|
8
|
6
|
|
| Accrued Liabilities |
2
|
1
|
2
|
3
|
3
|
3
|
3
|
4
|
1
|
1
|
|
| Short-Term Debt |
0
|
4
|
0
|
0
|
0
|
0
|
10
|
16
|
6
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
0
|
1
|
2
|
2
|
0
|
0
|
5
|
5
|
1
|
|
| Total Current Liabilities |
3
|
5
|
4
|
5
|
6
|
7
|
15
|
28
|
20
|
8
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
1
|
0
|
|
| Total Liabilities |
3
N/A
|
5
+109%
|
4
-19%
|
5
+19%
|
7
+26%
|
7
+0%
|
15
+123%
|
34
+126%
|
21
-38%
|
30
+42%
|
|
| Equity | |||||||||||
| Common Stock |
9
|
13
|
22
|
28
|
28
|
31
|
34
|
47
|
47
|
47
|
|
| Retained Earnings |
184
|
191
|
202
|
213
|
222
|
240
|
266
|
285
|
302
|
321
|
|
| Additional Paid In Capital |
185
|
188
|
216
|
210
|
210
|
222
|
238
|
305
|
305
|
305
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
9
N/A
|
10
+3%
|
37
+279%
|
26
-30%
|
16
-37%
|
13
-21%
|
7
-48%
|
67
+895%
|
49
-26%
|
31
-37%
|
|
| Total Liabilities & Equity |
12
N/A
|
15
+26%
|
41
+172%
|
31
-25%
|
23
-26%
|
20
-15%
|
22
+11%
|
101
+363%
|
70
-30%
|
61
-14%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
10
|
13
|
22
|
28
|
28
|
31
|
34
|
47
|
47
|
47
|
|
Switch to:
Switch to:
See Also
Discover More
